Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

aspen pharma schweiz gmbh - melphalanum - compresse rivestite con film - melphalanum 2 mg, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 171, pro compresso obducto. - farmaco - synthetika

Itália - italiano - AIFA (Agenzia Italiana del Farmaco)

aspen pharma trading limited - melfalan - melfalan

Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

aspen pharma schweiz gmbh - melphalanum - pulver und lösungsmittel zur herstellung einer injektions-/infusionslösung - praeparatio cryodesiccata: melphalanum 50 mg, povidonum k 12, acidum hydrochloridum pro vitro. solvens: natrii citras dihydricus corresp. natrium 46.9 mg, propylenglycolum, ethanolum 96 per centum 0.52 ml, aqua ad iniectabile q.s. ad solutionem pro 10 ml. - farmaco - synthetika

União Europeia - italiano - EMA (European Medicines Agency)

adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - agenti antineoplastici - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.

Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - estradioli valeras, dienogestum - compresse rivestite con film - i) dunkelgelbe tablette: estradioli valeras 3.000 mg, lactosum monohydricum 48.360 mg, maydis amylum, amylum pregelificatum, povidonum k 25, magnesii stearas, hypromellosum, macrogolum 6000, talcum, e 171, e 172 (flavum), pro compresso obducto. ii) mittelrote tablette: estradioli valeras 2.000 mg, dienogestum 2.000 mg, lactosum monohydricum 47.360 mg, maydis amylum, amylum pregelificatum, povidonum k 25, magnesii stearas, hypromellosum, macrogolum 6000, talcum, e 171, e 172 (rubrum), pro compresso obducto. iii) hellgelbe tablette: estradioli valeras 2.000 mg, dienogestum 3.000 mg, lactosum monohydricum 46.360 mg, maydis amylum, amylum pregelificatum, povidonum k 25, magnesii stearas, hypromellosum, macrogolum 6000, talcum, e 171, e 172 (flavum), pro compresso obducto. iv) dunkelrote tablette: estradioli valeras 1.000 mg, lactosum monohydricum 50.360 mg, maydis amylum, amylum pregelificatum, povidonum k 25, magnesii stearas, hypromellosum, macrogolum 6000, talcum, e 171, e 172 (rubrum), pro compresso obducto. v) weisse placebotablette: lactosum monohydricum 52.1455 mg, maydis amylum, povidonum k 25, magnesii stearas, hypromellosum, talcum, e 171, pro compresso obducto. - contraccezione orale - synthetika

Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

orion pharma ag - estradioli valeras, medroxyprogesteroni acetas - compresse - estradioli valeras 1 mg, medroxyprogesteroni acetas 2.5 mg, lactosum monohydricum 83 mg, maydis amylum, gelatina, magnesii stearas, pro compresso. - terapia ormonale sostitutiva dopo la menopausa - synthetika

Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

orion pharma ag - estradioli valeras, medroxyprogesteroni acetas - compresse - estradioli valeras 1 mg, medroxyprogesteroni acetas 5 mg, lactosum monohydricum 80.5 mg, maydis amylum, gelatina, magnesii stearas, pro compresso. - terapia ormonale sostitutiva dopo la menopausa - synthetika

Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

orion pharma ag - estradioli valeras, medroxyprogesteroni acetas - compresse - estradioli valeras 2 mg, medroxyprogesteroni acetas 5 mg, lactosum monohydricum 79.5 mg, maydis amylum, gelatina, magnesii stearas, pro compresso. - terapia ormonale sostitutiva dopo la menopausa - synthetika